+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Antiparasitic Drugs Market Outlook 2026-2034: by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Drug Type, Route of Administration, End-User

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6242448
UP TO OFF until Jan 01st 2027
The Antiparasitic Drugs Market is estimated at US$26.3 billion in 2026 and is projected to grow at a CAGR of 6.7% to reach US$44.2 billion by 2034.

Market Overview

The Antiparasitic Drugs Market covers drug therapies used to prevent and treat parasitic infections across human healthcare, travel medicine, hospital care, and public health programs.

Its value chain includes active ingredient suppliers, pharmaceutical manufacturers, distributors, hospitals, pharmacies, public health agencies, and clinical care providers. Core applications include intestinal parasite treatment, neglected tropical disease programs, hospital infectious disease care, travel medicine, community health campaigns, and prophylactic protocols.

Market Segmentation

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Drug Type

  • Anthelmintics
  • Antiprotozoals
  • Others

By Route of Administration

  • Oral
  • Injectable
  • Topical & Implants

By End-User

  • Hospitals
  • Clinics
  • Home-Care Settings

Key Companies Analysed

  • GSK
  • Novartis
  • Sanofi
  • Pfizer
  • Bayer
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical
  • Dr. Reddy’s Laboratories
  • Cipla
  • Aurobindo Pharma
  • Lupin
  • Macleods Pharmaceuticals
  • Ipca Laboratories
  • Ajanta Pharma
  • Fresenius Kabi
  • Merck & Co
  • Zydus Lifesciences
  • Viatris
  • Shin Poong Pharmaceutical
  • MMV

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Antiparasitic Drugs Market Overview
2.1. Antiparasitic Drugs Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Antiparasitic Drugs Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Antiparasitic Drugs Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Antiparasitic Drugs Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Antiparasitic Drugs Market Analysis By Distribution Channel, 2025-2034
5.2.1. Hospital Pharmacy
5.2.2. Retail Pharmacy
5.2.3. Online Pharmacy
5.3. Antiparasitic Drugs Market Analysis By Drug Type, 2025-2034
5.3.1. Anthelmintics
5.3.2. Antiprotozoals
5.3.3. Others
5.4. Antiparasitic Drugs Market Analysis By Route of Administration, 2025-2034
5.4.1. Oral
5.4.2. Injectable
5.4.3. Topical & Implants
5.5. Antiparasitic Drugs Market Analysis By End-User, 2025-2034
5.5.1. Hospitals
5.5.2. Clinics
5.5.3. Home-Care Settings
6. North America Antiparasitic Drugs Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Antiparasitic Drugs Market Analysis By Distribution Channel
6.3. North America Antiparasitic Drugs Market Analysis By Drug Type
6.4. North America Antiparasitic Drugs Market Analysis By Route of Administration
6.5. North America Antiparasitic Drugs Market Analysis By End-User
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Antiparasitic Drugs Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Antiparasitic Drugs Market Analysis By Distribution Channel
7.3. Europe Antiparasitic Drugs Market Analysis By Drug Type
7.4. Europe Antiparasitic Drugs Market Analysis By Route of Administration
7.5. Europe Antiparasitic Drugs Market Analysis By End-User
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Antiparasitic Drugs Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Antiparasitic Drugs Market Analysis By Distribution Channel
8.3. Asia-Pacific Antiparasitic Drugs Market Analysis By Drug Type
8.4. Asia-Pacific Antiparasitic Drugs Market Analysis By Route of Administration
8.5. Asia-Pacific Antiparasitic Drugs Market Analysis By End-User
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Antiparasitic Drugs Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Antiparasitic Drugs Market Analysis By Distribution Channel
9.3. Middle East and Africa Antiparasitic Drugs Market Analysis By Drug Type
9.4. Middle East and Africa Antiparasitic Drugs Market Analysis By Route of Administration
9.5. Middle East and Africa Antiparasitic Drugs Market Analysis By End-User
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Antiparasitic Drugs Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Antiparasitic Drugs Market Analysis By Distribution Channel
10.3. South and Central America Antiparasitic Drugs Market Analysis By Drug Type
10.4. South and Central America Antiparasitic Drugs Market Analysis By Route of Administration
10.5. South and Central America Antiparasitic Drugs Market Analysis By End-User
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Antiparasitic Drugs Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. GSK
11.2.2. Novartis
11.2.3. Sanofi
11.2.4. Pfizer
11.2.5. Bayer
11.2.6. Teva Pharmaceutical Industries
11.2.7. Sun Pharmaceutical
11.2.8. Dr. Reddy's Laboratories
11.2.9. Cipla
11.2.10. Aurobindo Pharma
11.2.11. Lupin
11.2.12. Macleods Pharmaceuticals
11.2.13. Ipca Laboratories
11.2.14. Ajanta Pharma
11.2.15. Fresenius Kabi
11.2.16. Merck & Co
11.2.17. Zydus Lifesciences
11.2.18. Viatris
11.2.19. Shin Poong Pharmaceutical
11.2.20. MMV
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • GSK
  • Novartis
  • Sanofi
  • Pfizer
  • Bayer
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical
  • Dr. Reddy’s Laboratories
  • Cipla
  • Aurobindo Pharma
  • Lupin
  • Macleods Pharmaceuticals
  • Ipca Laboratories
  • Ajanta Pharma
  • Fresenius Kabi
  • Merck & Co
  • Zydus Lifesciences
  • Viatris
  • Shin Poong Pharmaceutical
  • MMV

Table Information